---
title: "Medprin Regenerative Medical Technologies Co., Ltd. (301033.SZ)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/301033.SZ.md"
symbol: "301033.SZ"
name: "Medprin Regenerative Medical Technologies Co., Ltd."
industry: "Health Care Equipment"
datetime: "2026-05-21T09:14:53.576Z"
locales:
  - [en](https://longbridge.com/en/quote/301033.SZ.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/301033.SZ.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/301033.SZ.md)
---

# Medprin Regenerative Medical Technologies Co., Ltd. (301033.SZ)

## Company Overview

Medprin Regenerative Medical Technologies Co., Ltd. engages in the research, development, manufacture, and sale of implantable medical devices. The company offers artificial dura matermembrane patches, craniomaxillofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal, a dural sealant system; and 3D bioprinting applications serving patients internationally.

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Exchange | CN Market |
| Website | [www.medprin.com](https://www.medprin.com) |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: B
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 2026-05-21T04:30:13.000Z

**Overall: B (0.26)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 23 / 64 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

**Multi Score**: B

#### Style Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 26.63% |  |
| Net Profit YoY | 24.54% |  |
| P/B Ratio | 4.56 |  |
| Dividend Ratio | 1.06% |  |

#### Size Score Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 3733507182.79 |  |
| Revenue | 372771519.89 |  |

#### Multi Score Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 14.17% | B |
| Profit Margin | 29.37% | A |
| Gross Margin | 78.77% | A |
| Revenue YoY | 26.63% | A |
| Net Profit YoY | 24.54% | B |
| Total Assets YoY | 11.26% | B |
| Net Assets YoY | 12.64% | B |
| Cash Flow Margin | 103.81% | C |
| OCF YoY | 26.63% | A |
| Turnover | 0.43 | C |
| Gearing Ratio | 9.68% | A |

```chart-data:radar
{
  "title": "Longbridge Financial Score - Medprin Regenerative Medical Technologies Co., Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Style Score",
      "grade": "",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "26.63%",
          "rating": ""
        },
        {
          "name": "Net Profit YoY",
          "value": "24.54%",
          "rating": ""
        },
        {
          "name": "P/B Ratio",
          "value": "4.56",
          "rating": ""
        },
        {
          "name": "Dividend Ratio",
          "value": "1.06%",
          "rating": ""
        }
      ]
    },
    {
      "name": "Size Score",
      "grade": "",
      "indicators": [
        {
          "name": "Market Cap",
          "value": "3733507182.79",
          "rating": ""
        },
        {
          "name": "Revenue",
          "value": "372771519.89",
          "rating": ""
        }
      ]
    },
    {
      "name": "Multi Score",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "14.17%",
          "rating": "B"
        },
        {
          "name": "Profit Margin",
          "value": "29.37%",
          "rating": "A"
        },
        {
          "name": "Gross Margin",
          "value": "78.77%",
          "rating": "A"
        },
        {
          "name": "Revenue YoY",
          "value": "26.63%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "24.54%",
          "rating": "B"
        },
        {
          "name": "Total Assets YoY",
          "value": "11.26%",
          "rating": "B"
        },
        {
          "name": "Net Assets YoY",
          "value": "12.64%",
          "rating": "B"
        },
        {
          "name": "Cash Flow Margin",
          "value": "103.81%",
          "rating": "C"
        },
        {
          "name": "OCF YoY",
          "value": "26.63%",
          "rating": "A"
        },
        {
          "name": "Turnover",
          "value": "0.43",
          "rating": "C"
        },
        {
          "name": "Gearing Ratio",
          "value": "9.68%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 34.11 | 21/64 | 51.25 | 46.55 | 41.98 |
| PB | 4.56 | 52/64 | 6.69 | 6.00 | 5.36 |
| PS (TTM) | 10.02 | 46/64 | 15.30 | 13.97 | 12.68 |
| Dividend Yield | 1.06% | 25/64 | 0.99% | 0.87% | 0.80% |

## Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 01 | APT (688617.SH) | A | B | B | A | B | A |
| 02 | United Imaging Healthcare (688271.SH) | B | A | C | B | B | B |
| 03 | iRay (688301.SH) | B | A | D | C | A | B |
| 04 | YUYUE MEDICAL (002223.SZ) | B | C | C | A | C | B |
| 05 | Insight Lifetech (688712.SH) | B | A | E | A | A | B |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/301033.SZ/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/301033.SZ/norm.md)
- [Related News](https://longbridge.com/en/quote/301033.SZ/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/301033.SZ/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**